Tandheelkundige behandeling boneloss Upper jaw augmentation
Conditions
Interventions
Patients fulfilling all in- and exclusion criteria will be requested for
informed consent and scheduled for sinus floor elevation surgery. At surgery
patients will undergo sinus augmentation with mi
Sponsors
Universitair Medisch Centrum Sint Radboud
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: •Male or female patients aged 18-70 years •Patient is willing to give informed consent to participate in the study •Patient qualifies for sinus augmentation surgery •Presence of a maxillary, unilateral or bilateral, (partial) edentulism involving the premolar/molar areas •Presence of a residual alveolar ridge height between 3 and 8 mm
Exclusion criteria
Exclusion criteria: •Maxillary sinus pathology •Recent extractions in the involved area •Presence of a local or systemic disease or treatment affecting bone formation •Contamination of the (area around the) operative field •Infectious diseases •Bone metabolic disease •Psychologic instability •Neurological disorders that could influence mental validity •Female of child bearing potential, who are pregnant or breast-feeding •Cancer therapy including immune-suppression, chemotherapy and radiation •Patients in which primary stability could not be established •Previous entry into this study or participation in any other clinical trail within 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •Percentage of new bone formation will be evaluated by micro-CT and histological analysis of biopsy specimens; for each biopsy from each patient at 5 months after augmentation surgery •Function of the inserted endosseous dental implants, at different time-intervals after surgery •Pain •Health related quality of life (SF-36) •Economical evaluation | — |
Countries
Netherlands
Outcome results
None listed